C83 C82
Conditions
Interventions
Group 1: Routine examinations only.
Time from initial diagnosis.
Data collection:
- Pathology
- Diagnostics (CT, MRT, Sono, Labor, etc.)
- Radiology
- therapy (first line, second line, etc., maintena
Sponsors
Universitätsklinikum Ulm
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Confirmation of histological diagnosis of MZoL and FL by a reference pathologist. Consent form signed by the patient.
Exclusion criteria
Exclusion criteria: Lack of consent. Lack of legal capacity or insight. Inclusion of active therapy of FL in a clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Experience in the sense of gaining knowledge on the ground of daily practice is to be gathered based on an accompanying project of the reference pathologists, which in turn contributes to quality assurance. The existing exchange of experience within the scope of the pilot phase of the registry is to be extended and expanded to the FL, and experiences from registry activities are to be passed on promptly, which ultimately also serves the purpose of care and quality assurance. | — |
Secondary
| Measure | Time frame |
|---|---|
| The current register with the participating centres offers the chance to establish a national biobank for the relatively rare entity of the MZoL. The aim would be to establish the collection of biomaterials through the register. | — |
Countries
Germany
Contacts
Public ContactJacqueline Gökeler
Universitätsklinikum UlmInstitut für Experimentelle Tumorforschung
Outcome results
None listed